Forarm surgery. Unspecified injury of ulnar artery at forearm level, right arm, sequela
Conditions
Interventions
Intervention 1: Intervention group 1: 50 milligram in kilogram of magnesium sulfate 50% made by Shahid Ghazi Pharmaceutical Company of Tabriz with rupivacaine two tenths of a percent will inject. Inte
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: Candidate of forearm surgery ASA class 1 and 2 No Raynaud's disease Absence of any vascular disease No sickle cell anemia No history of allergy to the drugs used in the study Lack of cyanosis of the affected limb Do not use drugs and psychotropic substances No contraindication to intravenous anesthesia No more than one fracture in the body or surgery Absence of chronic pain syndrome Absence of neurological disorders in the hand
Exclusion criteria
Exclusion criteria: For any reason, local intravenous anesthesia may be terminated during surgery Not consent to participate in study Duration of operation less than 30 minutes or more than 90 minutes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensory block. Timepoint: From the beginning study to 24 hours. Method of measurement: Physical examination.;Motor block. Timepoint: From the beginning study to 24 hours. Method of measurement: Physical examination.;Pain. Timepoint: After filling the tourniquet, 15, 30 and 45 minutes after the start of surgery and 30, 60, 90 and 120 minutes after the end of surgery. Method of measurement: Visual analogue pain questionnaire.;Average use opioids. Timepoint: Within 24 hours after surgery. Method of measurement: View file. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Esmaeel Moshiri
Arak University of Medical Sciences
Outcome results
None listed